It has been well-known that the ephrin type-A receptor 2 (EphA2), a member of the ephrin family of receptor tyrosine kinases, is overexpressed in various cancer cell types and plays an important role in tumor growth, invasiveness, angiogenesis, and metastasis through the EphA2 signaling pathway. Here, NTRK1 is linked to cancer.